Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-02-22 @ 7:03 PM
Study NCT ID:
NCT00675350
Status:
COMPLETED
Last Update Posted:
2014-05-12
First Post:
2008-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors
Sponsor:
ChemGenex Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-07
First Submit QC Date:
None
Study First Post Date:
2008-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-09
Last Update Post Date:
2014-05-12
Last Update Post Date Type:
ESTIMATED